Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

Author: Bajetta Emilio   Catena Laura   Procopio Giuseppe   Dosso Sara   Bichisao Ettore   Ferrari Leonardo   Martinetti Antonia   Platania Marco   Verzoni Elena   Formisano Barbara   Bajetta Roberto  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.59, Iss.5, 2007-04, pp. : 637-642

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content